Comparative efficacy and safety of super-bioavailable itraconazole-130 mg once daily in obese and non-obese patients of glabrous tinea

• Main Authors: Manjunath Shenoy (Author), Abhishek De (Author), Bela Shah (Author), Anupam Das (Author), Abir Saraswat (Author), Koushik Lahiri (Author), Dhiraj Dhoot (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Obesity is considered one of the risk factors for dermatophytosis and warrants systemic therapy. Itraconazole is the most commonly used antifungal, but owing to pharmacokinetic challenges, super-bioavailable itraconazole (SITZ) was approved globally, recently. For the management of derma...